[Webinar] Keep Up With The Enhancement Of Medical Device Post-Market Surveillance In China: GMP, GSP, And NMPA Onsite Inspections



Tuesday, January 11, 2022, 8:00-9:00 AM Pacific Time (US and Canada)


Since the implementation of Order 739 Regulations on Supervision and Administration of Medical Devices in June 2021, China continues to enhance post-market surveillance on medical devices from multiple dimensions.

The production, supply, storage, transportation, after-sales maintenance services are inseparable from the quality and safety of medical devices. To strengthen regulatory supervision and ensure quality and safety of medical devices, the “new Regulations” stipulate that the NMPA may conduct extended inspections on business entities and individuals that provide products or services in activities such as medical device development, production, operation, and use. 

This webinar is to help our audiences better understand and meet the requirements of China’s Good Supply Practices (GSP) and Good Manufacturing Practices (GMP) and be aware of the possible inspections it may receive from NMPA after the product’s market approval.


1. Introduction to China’s regulation on medical device sales and production

 2. What are the possible types of NMPA inspections after market approval? What are the requirements and how to prepare for it?

3. Case study based on hands-on auditing experience

4. Takeaway and tips


Zhe Ji

QA Manager, Inspirative Medical

Zhe has over 15 years of experience in medical device quality assurance as a team leader for product lifecycle supervision in China. She has extensive hands-on experience in handling post-market recalls, adverse events, and inspections, submitting periodic reports, providing trainings, and maintaining communication with China NMPA.

Registration Link